Cell line · CVCL_1351

KYSE-30

Cancer cell line, Homo sapiens. Esophageal squamous cell carcinoma. 53 papers.

4 sourcescell-lines-2026-11-14-0.1.0

Cite this record

ConductScience Library. KYSE-30. Cell lines, record CVCL_1351. Release cell-lines-2026-11-14-0.1.0, 14 Nov 2026. https://conductscience.org/library/cell-lines/CVCL_1351

On this page

Cell line

As Cellosaurus gives it.

Name: KYSE-30
Accession: CVCL_1351
RRID: RRID:CVCL_1351
Synonyms: Kyse-30, KYSE 30, KYSE30, Kyse30, KYSE0030
Species: Homo sapiens (Human)
Sex: Male
Age at sampling: 64Y
Category: Cancer cell line
Diseases: Esophageal squamous cell carcinoma (NCIt C4024); Squamous cell carcinoma of the esophagus (ORDO Orphanet_99977)
Derived from: Esophagus (in situ)
Entry created: 2012-04-04
Entry updated: 2026-06-25

Source Cellosaurus

Problems0

Cellosaurus records no problem for this cell line.

None in this release.

Papers53

Paper	Journal	Year	How we know	Source
Identification of STAT1 as a biomarker for lymph node metastasis in esophageal squamous cell carcinoma.	J Mol Histol	2026	Its Methods give the RRID and name the line	PubMed
Comprehensive Pan-Cancer Analysis of ABCA1: Insights From Multi-Omics Data and Exploratory Validation in Esophageal Squamous Cell Carcinoma.	Cell Biochem Funct	2026	Its Methods give the RRID and name the line	PubMed
Elevated CHAF1A Suppresses Type I Interferon Production and Causes Immunotherapy Resistance in Esophageal Squamous Cell Carcinoma.	Cancer Immunol Res	2026	Its Methods give the RRID and name the line	PubMed
Suppression of AKT Activation through LZK Inhibition Limits Tumor Growth in Esophageal and Head and Neck Cancers.	Mol Cancer Ther	2026	Its Methods give the RRID and name the line	PubMed
Targeting VEGF signaling and stromal remodeling enhances chemoimmunotherapy efficacy in esophageal cancer.	J Immunother Cancer	2026	Its Methods give the RRID and name the line	PubMed
Lactylome Reprogramming Mediates Therapeutic Response and Adaptation to Neoadjuvant Chemotherapy in Esophageal Squamous Cell Carcinoma.	Mol Cell Proteomics	2026	Its Methods give the RRID and name the line	PubMed
USP5 regulates purine metabolism and represents a therapeutic target in esophageal cancer.	Cell Death Dis	2026	Its Methods give the RRID and name the line	PubMed
A Noncanonical RNA-Binding Function of NQO1 Drives Angiogenesis in Esophageal Squamous Cell Carcinoma via Extracellular Vesicle-Mediated AGRN Transfer.	Cancer Res	2026	Its Methods give the RRID and name the line	PubMed
NIPAL1 Drives a Metabolic-Epigenetic Feedback Loop to Promote Lactate-Mediated Immune Evasion in Esophageal Cancer.	Adv Sci (Weinh)	2026	Its Methods give the RRID and name the line	PubMed
Ectopic CD11c Drives SMAD3-Mediated Aberrant Antigen Presentation and Epithelial-Mesenchymal Transition in Esophageal Squamous Cell Carcinoma.	Cancer Commun (Lond)	2026	Its Methods give the RRID and name the line	PubMed

1 to 10 of 53

See all 53 papers

Relatives9

Relation	Cell line	Accession	Source
Derived from it	EDITGENE KYSE-30-FLUC	CVCL_F5TY	Cell lines
Derived from it	KYSE-30-EGFP	CVCL_E3F6	Cell lines
Derived from it	Ubigene KYSE-30 CCHCR1 KO	CVCL_E0WW	Cell lines
Derived from it	Ubigene KYSE-30 CYP26B1 KO	CVCL_E0WX	Cell lines
Derived from it	Ubigene KYSE-30 DDAH2 KO	CVCL_E0WY	Cell lines
Derived from it	Ubigene KYSE-30 FASN KO	CVCL_E0WZ	Cell lines
Derived from it	Ubigene KYSE-30 MCM10 KO	CVCL_E0X0	Cell lines
Derived from it	Ubigene KYSE-30 TNXB KO	CVCL_E0X1	Cell lines
Derived from it	Ubigene KYSE-30 ZNF750 KO	CVCL_E0X2	Cell lines

Cell banks9

Cell bank	Catalog number	Source
BCRJ	0404	BCRJ
CLS	305094	CLS
DSMZ	ACC-351	DSMZ
ECACC	94072011	ECACC
EDITGENE	EDC00323	EDITGENE
ICLC	HTL97022	ICLC
JCRB	JCRB0188	JCRB
NCBI_Iran	C584	Cellosaurus
Ubigene	YC-C054	Ubigene

Data dates

The date of each source this release read.

Cellosaurus: 2026-10-22; Cellosaurus
PubMed Central's articles: 2026-11-12; PubMed Central's articles
Our copy of PubMed: 2026-11-06; Our copy of PubMed

Sources 4

CellosaurusCC BY 4.0, with credit to Cellosaurus (SIB)
PubMed Central's articlesTitles shown only for CC0, CC BY and public domain articles
NLM's PMC Article DatasetsCourtesy of NLM, which does not endorse this database
PubMedNLM's terms

Each source's terms

CellosaurusCC BY 4.0. Cellosaurus's README: "we have chosen to apply the Creative Commons Attribution 4.0 International (CC BY 4.0) license to Cellosaurus (https://creativecommons.org/licenses/by/4.0/). This means that you are free to copy and redistribute Cellosaurus in any medium or format. You can remix, transform, and build upon Cellosaurus for any purpose, even commercially. You must give appropriate credit, provide a link to the license, and indicate if changes were made." Copyright (c) CALIPHO group, SIB Swiss Institute of Bioinformatics. Read on 14 Nov 2026 at https://ftp.expasy.org/databases/cellosaurus/README
PubMed Central's articlesEach article's own license. Its words show only under CC0, CC BY or public domain
NLM's PMC Article DatasetsNLM's PMC Article Datasets on AWS, https://registry.opendata.aws/ncbi-pmc. Its terms: users "acknowledge NLM as the source of the data in a clear and conspicuous manner", do not use the PubMed Central wordmark or the PMC logo, do not "indicate or imply that NLM/NIH/HHS has endorsed" a product, and "only distribute data that are licensed for redistribution". Each article keeps its own license: https://pmc.ncbi.nlm.nih.gov/about/copyright/
PubMedNLM's terms

Cellosaurus, SIB Swiss Institute of Bioinformatics, https://www.cellosaurus.org, CC BY 4.0. Its problem notes are given in its own words.

For software

Read this cell line from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/cell-lines/v1/CVCL_1351

GET https://conductscience.org/api/cell-lines/v1/CVCL_1351/papers?page=2

API reference For AI assistants